DEA Extends Ban on Drug With Unpronounceable Sci-Fi Name
Published Date: 12/11/2025
Rule
Summary
The DEA is extending the temporary ban on CUMYL-PEGACLONE, keeping it in the strictest drug category (Schedule I) for another year starting December 12, 2025. This means anyone making, selling, or using this substance faces serious legal rules and penalties until a permanent decision is made. The extension helps keep communities safe while the government finishes its review.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
CUMYL-PEGACLONE Kept in Schedule I
The DEA extended the temporary Schedule I placement of CUMYL-PEGACLONE (including its salts and isomers) effective December 12, 2025, through December 12, 2026, or until permanent scheduling occurs. While it is in Schedule I, the regulatory controls and the administrative, civil, and criminal sanctions that apply to Schedule I substances continue to apply to anyone who manufactures, distributes, imports, exports, researches, teaches with, chemically analyzes, or possesses this substance.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in